Back to Search Start Over

The erosion protection efficacy of a stabilized stannous fluoride dentifrice: An in situ randomized clinical trial.

Authors :
West NX
Hellin N
Eusebio R
He T
Source :
American journal of dentistry [Am J Dent] 2019 Jun; Vol. 32 (3), pp. 138-142.
Publication Year :
2019

Abstract

Purpose: To compare the enamel protection efficacy of a stabilized stannous fluoride dentifrice to a triclosan-containing sodium fluoride dentifrice using a 10-day in situ erosion model, in accordance with the American Dental Association Seal of Acceptance guidelines for enamel erosion control.<br />Methods: In this single-center, double-blind, randomized, supervised-usage, two-treatment, four-period, crossover study, healthy adult subjects were randomized to a treatment sequence involving the following products: a 0.454% stannous fluoride (1,100 ppm F) dentifrice (Procter & Gamble) and a control dentifrice containing 0.243% sodium fluoride (1,100 ppm F) and 0.3% triclosan (Colgate-Palmolive). Each study period consisted of 10 treatment days. Subjects wore an intra-oral appliance fitted with two polished human enamel samples for 6 hours per treatment day. While wearing the appliance, subjects swished with their assigned dentifrice slurry for 60 seconds twice daily and with 250 ml orange juice over a 10-minute period four times daily. After 10 days, enamel specimens were removed and measured for surface loss using contact profilometry.<br />Results: 36 subjects were enrolled and 33 completed the study (mean age = 41.8 years). The stannous fluoride dentifrice demonstrated 90.3% less enamel loss than the NaF/triclosan dentifrice (P < 0.001) at Day 10, with median enamel loss of 0.279 µm and 2.877 µm, respectively. Both products were well tolerated.<br />Clinical Significance: The stannous fluoride dentifrice provided significantly greater protection against dental erosion relative to the NaF/triclosan dentifrice.<br />Competing Interests: Dr. He and Ms. Eusebio are full-time employees of The Procter & Gamble Company. Prof. West and Ms. Hellin have undertaken clinical studies, and Prof. West has done consulting work, for The Procter & Gamble Company. The study was funded by The Procter & Gamble Company.<br /> (Copyright©American Journal of Dentistry.)

Details

Language :
English
ISSN :
0894-8275
Volume :
32
Issue :
3
Database :
MEDLINE
Journal :
American journal of dentistry
Publication Type :
Report
Accession number :
31295395